Cicinnati VR - Search Results

1

Treatment of hepatitis B reinfection after liver transplantation.

Beckebaum S, Cicinnati VR, Gerken G, Broelsch CE. Beckebaum S, et al. Among authors: cicinnati vr. Minerva Chir. 2003 Oct;58(5):705-16. Minerva Chir. 2003. PMID: 14603149 Review.

2

Daily interferon alpha-2B and ribavirin combination therapy for liver transplant patients with chronic hepatitis C infection.

Beckebaum S, Cicinnati VR, Karliova M, Dirsch O, Erim Y, Frilling A, Malago M, Broelsch CE, Treichel U, Gerken G. Beckebaum S, et al. Among authors: cicinnati vr. Transplant Proc. 2003 Sep;35(6):2080-1. doi: 10.1016/s0041-1345(03)00681-x. Transplant Proc. 2003. PMID: 14529846 No abstract available.

3

Combination therapy with peginterferon alpha-2B and ribavirin in liver transplant recipients with recurrent HCV infection: preliminary results of an open prospective study.

Beckebaum S, Cicinnati VR, Zhang X, Malago M, Dirsch O, Erim Y, Frilling A, Broelsch CE, Gerken G. Beckebaum S, et al. Among authors: cicinnati vr. Transplant Proc. 2004 Jun;36(5):1489-91. doi: 10.1016/j.transproceed.2004.05.017. Transplant Proc. 2004. PMID: 15251366 Clinical Trial.

4

[Advances and limitations of liver transplantation in Germany].

Beckebaum S, Cicinnati VR, Broelsch CE. Beckebaum S, et al. Among authors: cicinnati vr. Verh Dtsch Ges Pathol. 2004;88:45-50. Verh Dtsch Ges Pathol. 2004. PMID: 16892533 German.

5

Ribavirin with either standard or pegylated interferon to treat recurrent hepatitis C after liver transplantation.

Cicinnati VR, Iacob S, Klein CG, Baba HA, Sotiropoulos GC, Hilgard P, Erim Y, Broelsch CE, Gerken G, Beckebaum S. Cicinnati VR, et al. Aliment Pharmacol Ther. 2007 Jul 15;26(2):291-303. doi: 10.1111/j.1365-2036.2007.03363.x. Aliment Pharmacol Ther. 2007. PMID: 17593075

6

Role of osteopontin and CD44s expression for patients with hepatocellular carcinoma undergoing liver transplantation or resection.

Beckebaum S, Chen X, Sotiropoulos GC, Radtke A, Daoudaki M, Baba HA, Wohlschlaeger J, Broelsch CE, Gerken G, Cicinnati VR. Beckebaum S, et al. Among authors: cicinnati vr. Transplant Proc. 2008 Nov;40(9):3182-4. doi: 10.1016/j.transproceed.2008.08.034. Transplant Proc. 2008. PMID: 19010227

7

DNA-based immunotherapy: potential for treatment of chronic viral hepatitis?

Beckebaum S, Cicinnati VR, Gerken G. Beckebaum S, et al. Among authors: cicinnati vr. Rev Med Virol. 2002 Sep-Oct;12(5):297-319. doi: 10.1002/rmv.359. Rev Med Virol. 2002. PMID: 12211043 Review.

8

Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune escape.

Beckebaum S, Cicinnati VR, Zhang X, Ferencik S, Frilling A, Grosse-Wilde H, Broelsch CE, Gerken G. Beckebaum S, et al. Among authors: cicinnati vr. Immunology. 2003 Aug;109(4):487-95. doi: 10.1046/j.1365-2567.2003.01699.x. Immunology. 2003. PMID: 12871214 Free PMC article.

9

Efficacy of combined lamivudine and adefovir dipivoxil treatment for severe HBV graft reinfection after living donor liver transplantation.

Beckebaum S, Malagó M, Dirsch O, Cicinnati VR, Trippler M, Lampertico P, Lama N, Treichel U, Gerken G, Broelsch CE. Beckebaum S, et al. Among authors: cicinnati vr. Clin Transplant. 2003 Dec;17(6):554-9. doi: 10.1046/j.0902-0063.2003.00097.x. Clin Transplant. 2003. PMID: 14756274

10

[Recurrent disease after liver transplantation. A therapeutic dilemma or treatable?].

Beckebaum S, Cicinnati VR, Broelsch CE, Gerken G. Beckebaum S, et al. Among authors: cicinnati vr. Med Klin (Munich). 2006 Dec 15;101(12):939-50. doi: 10.1007/s00063-006-1118-5. Med Klin (Munich). 2006. PMID: 17171317 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters